跳到主要內容

Murphy Andrew J 的 Form 4 申報

Regeneron Pharmaceuticals, Inc.(REGN),2022/2/16 申報

申報編號
0001708138-22-000014
申報時間
2022/2/16
交易日
2022/2/14-2/15
申報延遲
2 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 13 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $222.8 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Murphy Andrew JCIK 0001796226高階主管(EVP Research)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/2/14Common StockM行使選擇權取得+10,000$179.13+$1,791,30068,470直接
2022/2/14Common StockF扣股繳稅處分−6,460$626.79−$4,049,063.462,010直接
2022/2/15Common StockS賣出處分−99$622.09F2−$61,586.9161,911直接
2022/2/15Common StockS賣出處分−50$625.90−$31,29561,861直接
2022/2/15Common StockS賣出處分−421$626.51F3−$263,760.7161,440直接
2022/2/15Common StockS賣出處分−630$627.49F4−$395,318.760,810直接
2022/2/15Common StockS賣出處分−520$628.62F5−$326,882.460,290直接
2022/2/15Common StockS賣出處分−533$629.35F6−$335,443.5559,757直接
2022/2/15Common StockS賣出處分−434$630.41F7−$273,597.9459,323直接
2022/2/15Common StockS賣出處分−185$631.67F8−$116,858.9559,138直接
2022/2/15Common StockS賣出處分−289$632.71F9−$182,853.1958,849直接
2022/2/15Common StockS賣出處分−220$633.54F10−$139,378.858,629直接
2022/2/15Common StockS賣出處分−159$634.43F11−$100,874.3758,470直接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2022/2/14Common StockM行使選擇權處分−10,000$0.00$030,000直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

Represents volume-weighted average price of sales of 99 shares of Company stock on February 15, 2022 at prices ranging from $622.00 to $622.10. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F3

Represents volume-weighted average price of sales of 421 shares of Company stock on February 15, 2022 at prices ranging from $626.08 to $626.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F4

Represents volume-weighted average price of sales of 630 shares of Company stock on February 15, 2022 at prices ranging from $627.00 to $627.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F5

Represents volume-weighted average price of sales of 520 shares of Company stock on February 15, 2022 at prices ranging from $628.09 to $628.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F6

Represents volume-weighted average price of sales of 533 shares of Company stock on February 15, 2022 at prices ranging from $629.00 to $629.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F7

Represents volume-weighted average price of sales of 434 shares of Company stock on February 15, 2022 at prices ranging from $630.18 to $630.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F8

Represents volume-weighted average price of sales of 185 shares of Company stock on February 15, 2022 at prices ranging from $631.29 to $631.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F9

Represents volume-weighted average price of sales of 289 shares of Company stock on February 15, 2022 at prices ranging from $632.28 to $632.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F10

Represents volume-weighted average price of sales of 220 shares of Company stock on February 15, 2022 at prices ranging from $633.26 to $633.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F11

Represents volume-weighted average price of sales of 159 shares of Company stock on February 15, 2022 at prices ranging from $634.23 to $634.56. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)